Fu et al. also have mentioned that blockade of the OX40–OX40L pathway in vivo generally improves the long‐term autoimmunity, mainly by preventing migration, moderating T cell polarization, altering inflammatory cytokine production, and preventing proliferation of active CD4+ T cells [39]. The gene discussed is CD4; the disease is Autoimmunity.